IP Library Granted Patent US 8,349,794
Granted Patent B2
US 8,349,794 · App. 12/204,922 · Granted Jan 8, 2013

Reconstitution medium for protein and peptide formulations

Assignee: The Research Foundation of State University of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,349,794
App. No.
12/204,922
Granted
Jan 8, 2013
Kind
B2
Abstract

Compositions useful for reconstitution of concentrated formulations containing protein/peptide pharmaceuticals are provided. The composition generally includes one or more lipids, as well as one or more alcohols that promote and stabilize the formation of (a) lipid molecular assemblies with greater protein encapsulation; (b) protein-lipid complexes and (c) protein and lipid solutions. The reconstitution medium improves the protein-lipid association that in turn alters the pharmaceutical properties.

Claims (16)

1. A method for reconstitution of a dry protein preparation to produce a stabilized reconstituted protein solution, said method comprising:

a) providing

i) a dry protein preparation, and

ii) a reconstitution medium comprising ethanol, wherein the ethanol is less than 60% of the reconstitution medium by volume, and wherein the reconstitution medium is buffered to a physiological pH,

wherein i) and/or ii) comprise lipids, wherein the lipids are selected from the group consisting of phosphatidyl serine, phosphatidyl choline, and combinations thereof; and

b) combining i) and ii) to form a stabilized reconstituted protein solution in which less than 30% of the protein is present in the form of aggregates as determined by size-exclusion chromatography.

2. A method as in claim 1 wherein the protein in the stabilized reconstituted protein solution maintains its tertiary structure as evidenced by circular dichroism.

3. A method as in claim 1 wherein the concentration of the one or more lipids is in the range of from 0.3 mM to 40 mM.

4. A method as in claim 1 wherein the buffer in the reconstitution medium comprises calcium ions.

5. A method as in claim 4 wherein the buffer concentration is 0.5 mM to 600 mM.

6. A method as in claim 1 wherein said dry protein preparation contains one or more lipid components selected from the group consisting of liposomes, micelles, cochleates, laminar, and lamellar structures, and combinations thereof, which are associated with the protein.

7. A method as in claim 1 wherein the dry protein preparation comprises Factor VIII.

8. A method as in claim 1 wherein the concentration of the ethanol is less than 20% by volume.

9. A method as in claim 8 wherein the concentration of the one or more alcohols in the stabilized reconstituted protein solution is in the range of from 5% by volume to 10% by volume.

10. The method of claim 1 , wherein the physiological pH is 7.2.

11. The method of claim 1 , wherein the protein has an accessible hydrophobic domain.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 27, 2012
From: THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028851/0332 →
CONFIRMATORY LICENSE Recorded Dec 13, 2010
From: STATE UNIVERSITY OF NEW YORK AT BUFFALO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025493/0440 →
Continuity (3)
Division 10911865 · Aug 5, 2004
Provisional Application 60492582 · Aug 5, 2003
Related Publication 20090062205A1 · Mar 5, 2009